PAA 2.56% 20.0¢ pharmaust limited

Ann: MND Trial Successfully Completes First Patient Cohort, page-2

  1. 11,920 Posts.
    lightbulb Created with Sketch. 6059
    Great Announcement , not only informative and engaging but includes Potential Commercial Value

    MPL Bespoke Tablets.

    Referring to the upcoming Human Covid trial also ,,NZT
    Last edited by NZ Trader: 06/01/23
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.